GlassScriptPhysician profile
Asad Choudhury
NPI 1508325747
$1,200.03
in general payments reported to CMS, 2019-2025
13 companies · $40.42 in 2025
The $40.42 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.13 · 2022: $271 · 2023: $382 · 2024: $491 · 2025: $40.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $913.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $250.00 | 2022 | |
| Alexion Pharmaceuticals, INC. | $236.37 | 2023-2024 | Ultomiris, Soliris |
| Janssen Pharmaceuticals, INC | $201.05 | 2022-2024 | Xarelto |
| Pfizer INC. | $118.33 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.58 | 2024 | Jardiance |
| La Jolla Pharmaceutical Company | $76.25 | 2024 | Giapreza, Xerava |
| Merck Sharp & Dohme LLC | $70.90 | 2024 | Zerbaxa, Dificid, Prevymis |
| Aimmune Therapeutics, INC. | $62.74 | 2023 | |
| Tetraphase Pharmaceuticals, INC. | $21.52 | 2025 | |
| Tactile Systems Technology INC | $18.74 | 2023 | Flexitouch Plus, Entre Plus |
| Sanofi-Aventis U.S. LLC | $16.41 | 2023 | |
| Mallinckrodt Hospital Products INC. | $16.13 | 2021 | |
| Gilead Sciences, INC. | $16.01 | 2023 | Veklury |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asad Choudhury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.